Cargando…
Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as a standard of care. Nevertheless, controversial reports have been published. The aim of the present study is to evaluate...
Autores principales: | Petrakis, Vasilis, Rapti, Vasiliki, Akinosoglou, Karolina, Bonelis, Constantinos, Athanasiou, Kalomoira, Dimakopoulou, Vasiliki, Syrigos, Nikolaos K., Spernovasilis, Nikolaos, Trypsianis, Grigoris, Marangos, Markos, Gogos, Charalambos, Papazoglou, Dimitrios, Panagopoulos, Periklis, Poulakou, Garyfallia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611983/ https://www.ncbi.nlm.nih.gov/pubmed/36296225 http://dx.doi.org/10.3390/microorganisms10101949 |
Ejemplares similares
-
Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice
por: Pantazis, Nikos, et al.
Publicado: (2023) -
Knowledge and Perceptions about COVID-19 among Health Care Workers: Evidence from COVID-19 Hospitals during the Second Pandemic Wave
por: Ioannou, Petros, et al.
Publicado: (2021) -
New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
por: Rapti, Vasiliki, et al.
Publicado: (2022) -
The Antiviral Effect of Nirmatrelvir/Ritonavir during COVID-19 Pandemic Real-World Data
por: Petrakis, Vasilios, et al.
Publicado: (2023) -
Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
por: Akinosoglou, Karolina, et al.
Publicado: (2023)